These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6178538)

  • 41. Comparative performance of three radioimmunoassays for prostatic acid phosphatase.
    Farnsworth WE; Gonder MJ; Cartagena R; Steinbach JJ
    Urology; 1980 Aug; 16(2):165-7. PubMed ID: 6157243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
    Perrin P; Clairet F; Fleury-Goyon MC; Durand L
    J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fundamental and clinical study of PAP 'Eiken' (author's transl)].
    Higuchi Y; Kida T
    Kaku Igaku; 1981 Dec; 18(10):1451-7. PubMed ID: 6176743
    [No Abstract]   [Full Text] [Related]  

  • 44. Histochemical changes of phosphatases in the prostatic gland.
    Aso Y; Hoshino Y; Okada K; Murahashi I; Takayasu H
    Invest Urol; 1968 Nov; 6(3):304-14. PubMed ID: 4177079
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation of a double antibody radioimmunoassay kit for prostatic acid phosphatase (PAP) (author's transl)].
    Yoshii M; Kousaka T; Morita R; Torizuka K; Kawamura J
    Kaku Igaku; 1981 Dec; 18(10):1473-83. PubMed ID: 6176744
    [No Abstract]   [Full Text] [Related]  

  • 46. Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
    Bauer HW; Göttinger H; Grenner G; Dati F
    Urol Res; 1981; 9(1):21-4. PubMed ID: 7022994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on prostatic phosphatase. II. Study on serum acid phosphatase].
    Nakano S
    Hinyokika Kiyo; 1969 Aug; 15(8):565-75. PubMed ID: 4186705
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
    Pontes JE; Choe BK; Rose NR; Ercole C; Pierce JM
    J Urol; 1981 Sep; 126(3):363-5. PubMed ID: 6168779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 51. [Changes in acid phosphatase levels during various prostatic operations].
    Vitsou-Georgallis H; Goulandris N; Marketos N; Dimopoulos C
    Acta Urol Belg; 1980 Oct; 48(4):488-97. PubMed ID: 6161530
    [No Abstract]   [Full Text] [Related]  

  • 52. Lactic dehydrogenase isozymes in benign and malignant prostatic tissues.
    Srinivasan V; Keil E; Villalba R; Baron T; Clark SS
    Invest Urol; 1973 Nov; 11(3):244-7. PubMed ID: 4127178
    [No Abstract]   [Full Text] [Related]  

  • 53. Metastatic carcinoma to the sphenoid sinus. Case report and review of the literature.
    McClatchey KD; Lloyd RV; Schaldenbrand JD
    Arch Otorhinolaryngol; 1985; 241(3):219-24. PubMed ID: 3896212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostatic acid phosphatase: current concepts.
    Romas NA
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy.
    Mahan DE; Bruce AW; Manley PN; Franchi L
    J Urol; 1980 Oct; 124(4):488-91. PubMed ID: 6158585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultracytochemical and biochemical study of acid and alkaline phosphatases in human prostatic cancer cell.
    Aso Y; Yokoyama M; Okada K; Tokue A; Koiso K
    Invest Urol; 1972 Jan; 9(4):329-34. PubMed ID: 4110265
    [No Abstract]   [Full Text] [Related]  

  • 58. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
    Hübler J; Jávor A
    Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
    Bruce AW; Mahan DE; Belville WD
    Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on acid phosphatase in prostatic cancer. IV. Immunochemical assay of prostatic acid phosphatase (author's transl)].
    Morishita N
    Nihon Hinyokika Gakkai Zasshi; 1980 Jun; 71(6):567-71. PubMed ID: 6159492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.